Skip to main content
NextGen MedPrep logoNextGenMedPrep
Back to Medical School Compare
Medical school comparison

Aberdeen vs King's College London (KCL)

Aberdeen and King's College London (KCL) are both UK medical schools, but the path to an offer at each is meaningfully different. Aberdeen is based in Aberdeen (Scotland) while King's College London (KCL) sits in London (London), and the regional context shapes everything from fee status to NHS-deanery destination.

Their A-Level requirements (AAA vs A*AA) place them in slightly different academic-strictness tiers. Aberdeen is the older institution (founded 1495); the other (founded 1829) has shaped its medical school around modern integrated-curriculum thinking.

Side-by-side comparison

Aberdeen

Aberdeen

Quick comparison

Location
Aberdeen, UK
A-Level offer
AAA at A-level
TrueScore
1700
UCAT home cut-off
-
Interview format
Multiple Mini Interviews (MMI)
Post-interview chance
RUK 74/165 = 45% (2025); Scottish 736/863 = 85%; International 101/140 = 72%
Decision date
March/April

King's College London (KCL)

London

Quick comparison

Location
London, UK
A-Level offer
A*AA at A-level including A in Biology and Chemistry
TrueScore
2150
UCAT home cut-off
~2130+ /2700 (non-contextual) with B1 SJT and 8× grade 8s at GCSE; mean offer holder ≈ 2250
Interview format
Multiple Mini Interviews (MMI)
Post-interview chance
All Students: 760/981 = 77% (2024); Overall undergraduate (2023): 645/1115 = 58%
Decision date
March onwards
Compare different schools

Aberdeen vs King's College London (KCL) - in detail

A-Level and academic profile

Aberdeen requires AAA including Chemistry and Biology/Physics/Mathematics.

King's College London (KCL) requires A*AA including Chemistry and Biology.

King's College London (KCL) is the stricter A-Level offer; Aberdeen is slightly more forgiving. If your predicted grades are borderline, Aberdeen carries the lower academic-rejection risk pre-interview.

Interview formats

Both Aberdeen and King's College London (KCL) use MMI interviews, so the underlying prep approach is the same — practise ethics frameworks, NHS hot-topic answers and (for MMI) structured station responses against a timer.

Interview windows: Aberdeen interviews in December - March; King's College London (KCL) in December - February.

Post-interview offer rate

Aberdeen: RUK 74/165 = 45% (2025); Scottish 736/863 = 85%; International 101/140 = 72%. King's College London (KCL): All Students: 760/981 = 77% (2024); Overall undergraduate (2023): 645/1115 = 58%.

Post-interview odds give you the clearest signal of how competitive each school is at the final stage — a school with a 60% post-interview success rate is structurally easier to convert than one at 25%, even if the interview thresholds look identical on paper.

What makes each distinctive

Aberdeen: Shortlisting weights academic 60% (A-level scores) / UCAT 40%. Scottish-domiciled applicants in the top 75% academically receive guaranteed interview. Care leavers and Quintile 1 postcode applicants receive a 10% UCAT uplift; Quintile 2 receives 5%.

King's College London (KCL): Strong clinical focus with emphasis on London healthcare system.

Which is right for you?

For applicants with predicted A-Level grades at the lower end of the AAA-A*AA range, Aberdeen is the lower-risk academic option. Regionally, the choice often comes down to cost of living and NHS-deanery preferences — Aberdeen feeds into the Scotland foundation programme network; King's College London (KCL) into the London network.

Your firm/insurance choice should ultimately weight: where your UCAT and predicted grades sit relative to each school's threshold, which interview format you can prepare for most credibly, and where you'd actually want to live for five or six years.

Common questions

Where to go next

AberdeenEntry requirements, interview format and key dates in fullKing's College London (KCL)Entry requirements, interview format and key dates in full

Other medical school comparisons

School data reviewed by the NextGen MedPrep editorial team — last reviewed 4 August 2026.